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CHAPTER 6
The influence of  different soft-tissue 
grafting procedures at single implant 
placement on aesthetics:





To assess whether grafting the buccal peri-implant mucosa using either a connective tissue 
graft (CTG) or xenogeneic collagen matrix (XCM) at implant placement in preserved alveolar 
ridges results in less mid-buccal mucosa recession compared to no grafting.
Materials & Methods:
Sixty patients randomly received either no graft (n=20, NG group), a CTG (n=20, CTG 
group) or XCM (Mucograft®, Geistlich Pharma AG, Wolhusen, Switzerland; n=20, XCM 
group) when placing an implant in a preserved alveolar ridge. Changes in mid-buccal mucosal 
level (MBML) at one (T1) and twelve (T12) months after final implant crown placement was 
compared to the pre-extraction situation. Additionally, aesthetics, marginal bone level, clinical 
peri-implant parameters and patient satisfaction were assessed. 
Results:
At T12, mean changes in MBML were -0.48±1.5 mm, -0.04±1.1 mm and -0.17±1.3 mm in the 
NG, CTG and XCM groups (p=0.56), respectively. Regarding the other outcome variables, 
no significant inter-group differences were observed.
Conclusion:
Soft tissue grafting at single implant placement in preserved alveolar ridges does not result 
in a better aesthetic outcome or in better peri-implant health and should not be considered 
as a standard procedure.











Single implant treatment in the maxillofacial aesthetic zone to replace a single failing tooth is 
a valuable treatment modality (den Hartog et al. 2008, Jung et al. 2012). However, long term 
data demonstrated stable aesthetics in just 37% of  the cases (Rokn et al. 2016).
It is presumed that to achieve stable aesthetics, the implant should be inserted in an optimal 
three-dimensional position in the available bone dimensions with preservation of  sufficient 
buccal bone volume for a proper soft tissue support (Merheb et al. 2014, Chappuis et al. 2017). 
Since the buccal bone wall in most sites of  the maxillary aesthetic zone is very thin (≤1 mm; 
Januario et al. 2011) and is associated with significant buccal bone resorption following tooth 
removal (Avila-Ortiz et al. 2014, Lee & Poon 2017), correct three-dimensional implant place-
ment might be impaired. Therefore, to reduce bone dimensional changes, augmentation of  
the extraction socket prior to implant placement was proposed to preserve both the alveolar 
ridge (Araújo et al. 2015, MacBeth et al. 2017) and buccal soft tissue (Barone et al. 2013). 
However, bone loss in width and height is still expected despite alveolar ridge preservation, 
as well as soft tissue changes (Ten Heggeler et al. 2011, Barone et al. 2013). 
To compensate for soft tissue changes, the application of  a connective tissue graft (CTG) was 
proposed to increase soft tissue volume (Thoma et al. 2009, Buser et al. 2017) and to establish 
a better soft tissue profile. According to the literature, grafting the buccal peri-implant soft 
tissue with a CTG effectively increases the soft tissue contour (Wiesner et al. 2010, Schneider 
et al. 2011, De Bruyckere et al. 2015, Hanser & Khoury 2016, Stefanini et al. 2016). Addition-
ally, connective tissue grafting (CT grafting) was demonstrated to be effective in preserving 
the mid-buccal mucosal level (Schneider et al. 2011, Stefanini et al. 2016, Zuiderveld et al. 
2018). In contrast to this, a retrospective study (Bienz et al. 2017) showed that CT grafting 
resulted in minimal changes of  soft tissue volume and level without a significant difference 
compared to no soft tissue grafting over 5 years follow-up. 
As an alternative to CTG as golden standard for soft tissue augmentation (Thoma et al. 
2014a, b), the use of  a xenogeneic collagen matrix (XCM) was introduced to decrease patient 
morbidity caused by the harvesting procedure of  the CTG (Sanz et al. 2009, Herford et al. 
2010). In several studies, applying a XCM to increase soft tissue thickness was found to be 
as effective as a CTG (Lorenzo et al. 2012, Thoma et al. 2016, Zeltner et al. 2017). XCM was 
also demonstrated to be effective on the long term with stable aesthetics (Maiorana et al. 
2018). In contrast to this, Cairo et al. (2017) observed a more effective increase in soft tissue 
thickness with the application of  CTG than with XCM. In terms of  recession reduction using 
a coronally advanced flap (CAF) with either a CTG or XCM, both achieved comparable and 
stable results (Cardaropoli et al. 2012, Jepsen et al. 2013). 
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As far as we know, Froum et al. (2015) is the only study comparing the effect of  applying a 
XCM with no soft tissue graft during implant placement. They found no differences between 
the groups, but intra-group comparisons revealed that, compared to baseline levels, patients 
receiving the XCM showed a significant thickening of  the buccal keratinized tissue. There is 
a paucity of  papers evaluating the effect of  applying a CTG or XCM on mid-buccal mucosa 
recession, although CT grafting has demonstrated to be effective and XCM was judged to be 
comparable to CTG. Therefore, we assessed whether grafting the buccal peri-implant mucosa 
using either a CTG or XCM at implant placement in preserved alveolar ridges results in less 
mid-buccal mucosa recession compared to no grafting.
Materials & Methods
Study design
Between December 2012 and July 2015, all consecutive patients (≥18 years) referred for 
implant treatment due to a maxillary single failing tooth (incisor, canine, first premolar) were 
invited to participate in this randomized controlled clinical study. The study was approved by 
our Medical Ethical Committee (NL43085.042.13) and registered in the Dutch trial register 
(www.trialregister.nl: NTR3815; 01-23-2013). The following in- and exclusion criteria had 
to be fulfilled: adequate oral hygiene (i.e., modified plaque and sulcus bleeding index ≤1; 
Mombelli et al. 1987), diastema width of  ≥6 mm and sufficient interocclusal space for a 
non-occluding temporary crown, no medical and general contraindications for the surgical 
procedure (i.e., ASA score ≥III; Smeets et al. 1998), no active and uncontrolled periodontal 
disease (probing pocket depths ≥4 mm and bleeding on probing (index score >1)), non-
smoker, no head and neck radiation, not pregnant (Fig. 1). Patients provided written informed 
consent before enrollment. 
According to a pre-operative cone beam computed tomography scan, insufficient bone 
volume on the palatal side was present to place an implant with primary stability. Addition-
ally, all patients presented with a vertical buccal bone wall defect of  >5 mm of  the extraction 
socket, assessed post-extraction by a bone sounding technique. Therefore, all extraction 
sockets were augmented prior to implant insertion and closed with a mucosa graft. Four 
months thereafter, patients were treated with an implant (NobelReplace CC, Nobel Biocare 
AB, Gothenburg, Sweden) and then randomly distributed, via sealed envelopes opened by an 
uninvolved research-nurse, to receive either: 










• no soft tissue graft (No graft group; NG group, n=20);
• a connective tissue graft harvested from the palate (Connective tissue graft group; CTG 
group, n=20);
• a xenogeneic collagen matrix (Mucograft®, Geistlich Pharma AG, Wolhusen, Switzerland) 
(Xenogeneic collagen matrix group; XCM group, n=20).
Fig. 1 – Cohort flow diagram
Assessed for eligibility (n=60) Enrollment 
Excluded (n=0) 
‐ Not meeting inclusion criteria 
- Declined to participate 
- Other reasons 
Randomized (n=60) 
Lost to follow-up (n=0) 
Discontinued intervention (n=0) 
Analysed (n=20) 
‐ Excluded from analysis (n=0) 
Allocated to intervention: No graft group 
(NG group; n=20) 
‐ Received allocated intervention (n=20) 





Allocated to intervention: Connective tissue 
graft group (CTG group; n=20) 
‐ Received allocated intervention (n=20) 
‐ Did not receive allocated intervention 
(n=0) 
Allocated to intervention: Xenogeneic 
collagen matrix group (XCM group; n=20) 
‐ Received allocated intervention (n=20) 
‐ Did not receive allocated intervention 
(n=0) 
Lost to follow-up (n=0) 
Discontinued intervention (n=0) 
Lost to follow-up (n=0) 
Discontinued intervention (n=0) 
Analysed (n=20) 
‐ Excluded from analysis (n=0) 
Analysed (n=20) 
‐ Excluded from analysis (n=0) 
Intervention procedure
One day prior to implant surgery, patients started taking antibiotics (amoxicillin 500mg, t.i.d. 
for 7 days or clindamycin 300mg, q.i.d. for 7 days in case of  amoxicillin allergy) and used a 
0.2% chlorhexidine mouthwash (twice daily for 7 days) for oral disinfection. 
All surgical procedures were performed under local anaesthesia by the same oral and maxillo-
facial surgeon (G.M.R.). In all groups, the extraction socket was augmented with the tuberosity 
bone graft shaped to match the buccal bone defect and inserted with the cortical side facing 
the periosteum (Fig. 2a). A mixture of  autologous bone and Bio-Oss® (Geistlich Pharma AG) 
spongious bone substitute (0.25-1.0 mm) was tightly packed into the extraction socket (Fig. 
2b). Then, the extraction socket was closed with a full-thickness mucosa graft (Fig. 2c), which 
was also harvested from the maxillary tuberosity region. 
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Fig. 2a – Clinical view of  the tuberosity bone graft in the extraction socket grafting the 
buccal bone defect.
Fig. 2b – Clinical view of  a mixture of  autologous bone and Bio-Oss® spongious bone 
substitutes tightly packed into the extraction socket.










Fig. 2c – Clinical view of  the extraction socket closed with a full-thickness mucosa graft. 
The implant was inserted four months after the augmentation procedure (Fig. 3). A small 
palatal crest-incision was made to expose the alveolar ridge, followed by extensions through 
the buccal and palatal sulcus of  the adjacent teeth and a divergent relieving incision at the distal 
tooth to elevate the minimal mucoperiosteal flap. The implant site was prepared according to 
the manufacturer’s manual and with a surgical template representing the ideal position of  the 
prospective implant crown. All implants were installed with a torque controller (OsseoCare, 
Nobel Biocare AB) with 45Ncm and provided with a cover screw. The implant shoulder was 
placed 3 mm apical to the most facial and cervical aspect of  the prospective clinical crown to 
ensure a proper emergence profile, including being levelled with the alveolar bone. 
The randomization procedure was done immediately after implant installation. Regarding the 
CTG group, the CTG was harvested from the palate (Fig. 4). 
Both the CTG and the XCM were placed in the prepared mucoperiosteal flap at the facial site 
and secured with vertical and horizontal mattresses (4-0 vicryl, Johnson & Johnson Gateway, 
Piscatatway, USA; Figs. 5a-d). The control group did not have a graft placed in the prepared 
mucoperiosteal flap. In all groups, the wound at the implant site was closed with Ethilon 
5-0 nylon sutures (Johnson & Johnson). All sutures were removed two weeks after surgery. 
During the healing phase, patients wore a removable partial denture that did not interfere 
with the wound. 
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Fig. 3 – Clinical view of  the implant placed in the pre-augmented alveolar ridge.
Fig. 4 – Harvesting procedure of  the connective tissue graft from the palate. 










Figs. 5a, b – Placement of  the connective tissue graft in the prepared mucoperiosteal 





Figs. 5c, d – Placement of  the xenogeneic collagen matrix in the prepared mucoperiosteal 
envelope flap, which was secured with horizontal and vertical mattresses.
c
d










After three months, the implants were uncovered and an implant-level impression was made 
for the fabrication of  a screw-retained provisional crown in the dental laboratory. All implants 
had been installed with a healing abutment (Nobel Biocare AB). The provisional crown was 
fitted that same day onto the implant with 20Ncm by a manual torque wrench (Nobel Biocare 
AB) and adjusted to function free from centric and eccentric contacts with the antagonist 
teeth. Patients were instructed to follow a soft diet and to avoid exerting force on the provi-
sional restoration. 
Three months later, a final open-tray implant-level impression was taken using polyether 
impression material (Impregum Penta, 3M ESPE, Seefeld, Germany). An individualized zir-
conia abutment (NobelProcera, Nobel Biocare AB) was made from the digitally designed 
final implant crown. Depending on the location of  the screw access hole, the final crown was 
screw-retained or cement-retained. Abutment screws were torqued with 35Ncm. 
All prosthetic procedures were accomplished by two prosthodontists (H.J.A.M. and C.S.).
Photographic assessment
The primary outcome measure was the change in mid-buccal mucosal level (MBML), assessed 
from standardized intra-oral photographs (Canon EOS 650D with ring flash) taken before 
tooth extraction (Tpre), one (T1) and 12 months (T12) after final implant crown placement. 
Changes in inter-proximal mucosal levels (IML) were measured the same way. The photo-
graphs were calibrated by a periodontal probe (Williams Color-Coded probe; Hu-Friedy, 
Chicago, IL, USA) held close to and parallel to the long axis of  the tooth next to the implant. 
Full-screen analysis was done using Adobe Photoshop CS5.1 (Adobe Systems Inc., San Jose, 
USA). MBML changes were measured at Tpre and T1 by drawing a horizontal line through the 
incisal edges of  the adjacent teeth and the distance between this line and the mucosal margin 
was calculated (Fig. 6a). The T1-T12 MBML changes were assessed from the length of  the 
implant crown (Fig. 6b). MBML changes between Tpre and T12 were calculated by adding both 
measurements (Zuiderveld et al. 2018). 
Peri-implant mucosa and implant crown aesthetics were assessed from photographs taken 
at T12 using the Pink Esthetic Score-White Esthetic Score (PES/WES; Belser et al. 2009). 
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Fig. 6a – Measurement of  change in MBML between Tpre and T1.
Fig. 6b – Measurement of  change in MBML between T1 and T12.











At T1 and T12, the marginal bone level was measured on standardized digital intra-oral radio-
graphs taken with an individualized device (Meijndert et al. 2004). The distance between the 
implant platform and first bone-to-implant contact along the implant was measured using 
specifically designed software. Bone above the implant platform was scored as no bone loss.
Clinical assessments
Clinical data of  any implant was collected by a single examiner (E.G.Z.), who was blinded 
regarding group allocation, at T1 and T12. The following parameters were assessed: (1) gingival 
biotype, as measured by means of  transparency of  a periodontal probe through the gingival 
margin of  the failing tooth (only at Tpre; Kan et al. 2010); (2) probing pocket depth using a 
periodontal probe at the mesio-buccal, mid-buccal, and disto-buccal and mid-palatal aspect; 
(3) amount of  plaque (modified plaque index; Mombelli et al. 1987); (4) bleeding after probing 
(modified sulcus bleeding index; Mombelli et al. 1987); (5) gingival condition (gingival-index; 
Loe 1967); (6) width of  the keratinized mucosa: no keratinized mucosa, <1 mm of  keratinized 
mucosa, 1-2 mm of  keratinized mucosa, ≥2 mm of  keratinized mucosa; (7) volume of  the 
interproximal papilla, using the papilla index (Jemt 1997); (8) implant survival; (9) implant 
success, defined as ≤1 mm marginal bone loss one-year post-loading and ≤0.2 mm there- 
after and the absence of  pain, infection, mobility, peri-implant radiolucency and alteration in 
sensitivity (Albrektsson et al. 1986).
Patient satisfaction
OHIP-14 questionnaires (van der Meulen et al. 2012), including questions about overall satis-
faction with the current dentition and compared to the pre-operative situation to be answered 
on a 10 cm Visual Analogue Scale (VAS), were completed at Tpre, T1 and T12. Additionally, 
questions regarding aesthetics and satisfaction with the treatment procedure to be answered 
on a 10 cm VAS were provided. All questionnaires were handed out and filled in privately 
before collecting the clinical data.
Statistical analysis
G*power 3.1 was used to calculate the sample size (Faul et al. 2009). A recession of  the 
mid-buccal mucosa of  0.5 mm from implant placement to 12 months after placement of  the 
final implant crown was considered to be a clinically relevant difference between the groups. 
With an expected standard deviation of  0.6 mm, as derived from the literature (Slagter et 
al. 2016), and a power of  80%, a minimum of  18 patients per group would be needed. We 
decided to include 20 patients per group in case of  any withdrawals from the study. 
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The Shapiro-Wilk test was used to assess the normal distribution of  the continuous variables 
and Normal Q-Q-plots were depicted. Normal distributed data were analysed using ANOVA. 
Non-normal distributed data were evaluated with Kruskal-Wallis tests. Within-group com-
parisons were done using Wilcoxon tests. Analysis of  categorical data was performed with 
Chi-square or Fisher’s exact tests. 
The Pearson’s correlation coefficient was calculated to explore the influence of  gingival bio-
type on the mid-buccal mucosal level. 
All analyses were done using a p-value of  0.05 to indicate statistical significance and were 
performed using SPSS (SPSS Statistics 23.0, SPSS Inc.; IBM Corporation, Chicago, IL, USA).
 
Results
Baseline characteristics of  the 60 included patients are depicted in Table 1. No significant 
differences between the groups were noticed for sex, age, gingival biotype, implant site loca-
tion, implant length and implant diameter. All patients received their assigned treatment (Fig. 
1). Figures 7a-c are showing the pre-operative clinical situation and the clinical situation one 
year after placement of  the final implant crown in the NG, CTG and XCM groups, respect-
ively. No signs of  soft tissue complications, nor extensive bleedings or perforation through 
the maxillary sinuses were noted at the donor site. During follow-up, no objective signs of  
infections were observed. No implants had been lost at T12 (implant survival rate of  100%) 
and none of  them displayed marginal bone loss in excess of  1 mm; they also fulfilled all the 
other success criteria (success rate of  100%).
Table 1 – Patient characteristics per study group. 
Variable
NG group CTG group XCM group
(n=20) (n=20) (n=20)
Male/female ratio 7/13 11/9 7/13








Gingival biotype thin/thick 15/5 13/7 10/10
Implant site location I1/I2/C/P1 9/8/0/0 16/3/1/0 11/4/3/2
Implant length (mm) 13/16 10/10 11/9 12/8
Implant diameter (mm) 3.5/4.3 9/11 4/16 5/15
Abbreviations: NG group, No graft group; CTG group, Connective tissue graft group; 
XCM group, Xenogeneic collagen matrix group.










Reliability of  photographic and radiographic measurements
Interclass correlations (ICCs) for the photographic measurements were high: 0.88 (95% CI 
0.72-0.95) and 0.83 (95% CI 0.60-0.93) for the intra- and inter-observer agreements, respect-
ively. The same applied for radiographic measurements: 0.71 (95% CI 0.32-0.87) and 0.9 (95% 
CI 0.75-0.96) for the intra- and interobserver agreements. The ICCs for aesthetic assessments 
were 0.86 (95% CI 0.68-0.94) and 0.90 (95% CI 0.77-0.96) for the intra- and interobserver 
agreements, respectively (Zuiderveld et al. 2018). 
Change in mid-buccal and interproximal mucosal level 
No significant differences in MBML changes between the groups were observed (Table 2). At 
T12, the MBML showed an average loss, compared to baseline levels, of  0.48±1.5 mm in the 
NG group, 0.04±1.1 mm in the CTG group and 0.17±1.3 mm in the XCM group (p=0.56). 
The changes in MBML between Tpre and T1 and between T1 and T12 were negligible in all 
groups (p=0.67 and p=0.15, respectively). Pre-treatment gingival biotype had no influence. 
IML changes at T12 of  both implant sides were comparable for the control and both test 
groups (mesial: p=0.63; distal: p=0.85; Table 2).
Change in radiographic marginal bone level 
Between T1 and T12 median (IQR) marginal bone level changes were 0.00 (-0.18-0.00) for the 
mesial side and 0.00 (-0.02-0.39) for the distal side in the NG group, respectively. For the CTG 
group changes were 0.00 (-0.13-0.01) and 0.00 (-0.29-0.06) and for the XCM group changes 
were 0.00 (-0.21-0.27) and 0.00 (-0.08-0.15), respectively. Changes were comparable between 
the groups (mesial side: p=0.67, distal side: p=0.24; Table 2). 
Clinical outcome 
Outcomes concerning probing pocket depths and papilla volume around the implant crown 
at T1 and T12 are depicted in Table 2. None of  the implant crowns displayed plaque at T12. 
Upon probing, 55% of  the patients in the NG and CTG groups and 45% in the XCM group 
demonstrated no bleeding (score 0). 30% of  the NG and CTG patients and 40% of  XCM 
patients had an isolated bleeding spot (score 1). A score 2 (confluent red line) was encountered 
in 15% of  the patients of  all the groups. 
At T12, the peri-implant mucosa was healthy in almost all patients; the exceptions were one 
patient in the NG group and one in the CTG group who showed signs of  mild inflammation. 
90%, 75% and 70% of  the patients in the NG, CTG and XCM respective groups displayed 
more than 2 mm of  keratinized mucosa (score 3). A 1-2 mm wide zone of  keratinized mucosa 
(score 2) was seen respectively in 5%, 15% and 10% of  the NG, CTG and XCM groups. 5% 
of  the patients in the XCM group had a keratinized mucosa of  up to 1 mm (score 1). 5%, 
10% and 15%, respectively, of  the patients in the NG, CTG and XCM groups showed no 




No significant inter-group differences were found with respect to PES and WES total scores 
as well as all the separate scoring items (Table 2). Acceptable levels of  aesthetics (PES/WES 
≥6) were reached in 75% of  the NG group, 80% of  the CTG group and 65% of  the XCM 
group regarding the peri-implant mucosa. With respect to the implant crown, acceptable 
levels were reached in 100% of  the NG group, 100% of  the CTG group and 95% of  the 
XCM group. 
Patient satisfaction
At T12, the results of  the VAS-scores showed no difference in patient satisfaction, except for 
satisfaction with the implant and implant crown (Table 3). Satisfaction with the current dental 
situation improved significantly between baseline and T1 (p=0.00), where after no further 
improvement was observed up to one year after placement of  the final crown (T12; p=0.94).
No inter-group differences were found for the total OHIP-questionnaire scores. Within-group 
comparisons showed a favourable improvement between Tpre and T1 (p=0.00), which con- 
tinued between T1 and T12 (p=0.00).  










Fig. 7a – NG group:
a 
b
a Pre-operative clinical situation of  the failing left central incisor.
b Clinical situation one year after placement of  the left central final implant crown. 
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Fig. 7b – CTG group:
a
b
a Pre-operative clinical situation of  the failing left central incisor.
b Clinical situation one year after placement of  the left central final implant crown.   










Fig. 7c – XCM group:
a
b
a Pre-operative clinical situation of  the failing left central incisor.
b Clinical situation one year after placement of  the left central final implant crown.
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Table 2 – Changes in marginal soft tissue level from baseline to twelve months after final
outcome measures.




























Variable Tpre – T1 (mean±SD) p-value T1 – T12 (mean±SD) p-value Tpre – T12 (mean±SD) p-value
MBML (mm) -0.34±1.5 -0.01±1.1 -0.001±1.3 0.67 -0.15±0.2 -0.03±0.2 -0.16±0.2 0.15 -0.48±1.5 -0.04±1.1 -0.17±1.3 0.56
IML (mm)
   Mesial of  implant

























Tpre (median (IQR)) T1 (median (IQR)) T12 (median (IQR))
MBL (mm)
   Mesial of  implant


















Tpre (mean±SD) T1 (mean±SD) T12 (mean±SD)
PES total (0-10)
   Mesial papilla
   Distal papilla
   Curvature of  facial mucosa
   Level of  facial mucosa
   Root convexity/soft tissue 
   colour and texture

























   Tooth form
   Outline/volume
   Colour (hue/value)
   Surface texture
   Translucency/characterization
PES/WES total (0-20)




























Probing pocket depth (mm)
   Mesial of  implant
   Mid-buccal of  implant 
   Distal of  implant 
   Palatal of  implant 











































Table 2 – Changes in marginal soft tissue level from baseline to twelve months after final
outcome measures.




























Variable Tpre – T1 (mean±SD) p-value T1 – T12 (mean±SD) p-value Tpre – T12 (mean±SD) p-value
MBML (mm) -0.34±1.5 -0.01±1.1 -0.001±1.3 0.67 -0.15±0.2 -0.03±0.2 -0.16±0.2 0.15 -0.48±1.5 -0.04±1.1 -0.17±1.3 0.56
IML (mm)
   Mesial of  implant

























Tpre (median (IQR)) T1 (median (IQR)) T12 (median (IQR))
MBL (mm)
   Mesial of  implant


















Tpre (mean±SD) T1 (mean±SD) T12 (mean±SD)
PES total (0-10)
   Mesial papilla
   Distal papilla
   Curvature of  facial mucosa
   Level of  facial mucosa
   Root convexity/soft tissue 
   colour and texture

























   Tooth form
   Outline/volume
   Colour (hue/value)
   Surface texture
   Translucency/characterization
PES/WES total (0-20)




























Probing pocket depth (mm)
   Mesial of  implant
   Mid-buccal of  implant 
   Distal of  implant 
   Palatal of  implant 
































































Mesial/distal of  implant
   No papilla (score 0)
   Less than half  papilla (score 1)
   At least half  papilla (score 2)
   Entire papilla (score 3)
   Hyperplastic papilla (score 4)































Resulting negative values of  subtracting the baseline value (Tpre) from T1 and T1 from T12 means 
recession, positive values mean tissue gain. 
Abbreviations: NG group, No graft group; CTG group, Connective tissue graft group; XCM group, 
Xenogeneic collagen matrix group; Tpre, pre-operative; T1, one month after final crown placement; 
T12, twelve months after final crown placement; MBML, mid-buccal mucosal level; IML, 
interproximal mucosal level; MBL, marginal bone level.
NA=Not assessed; PES/WES not assessed at Tpre and T1, since T12 was most meaningful.




























Tpre (median (IQR)) p-value T1 (median (IQR)) p-value T12 (median (IQR)) p-value
VAS-questions (0-10)








0.65 8.1 (7.4-8.9) 7.5 (7.2-8.2) 8.8 (7.9-9.7) 0.01 8.2 (7.4-8.8) 7.9 (6.8-9.0) 8.8 (7.6-9.6) 0.27
How satisfied are you with 
your current dental situation 
compared to the situation 
before treatment? 
-- -- -- 8.6 (8.0-9.7) 8.4 (7.5-9.3) 9.2 (7.8-9.9) 0.37 8.5 (7.8-9.1) 8.5 (8.2-9.7) 9.3 (8.7-9.6) 0.15
How satisfied are you with the 
implant and the implant crown?
-- -- -- 8.9 (7.9-9.6) 8.6 (8.0-9.2) 9.7 (8.9-10.0) 0.02 8.7 (8.3-9.5) 8.4 (6.9-9.2) 9.3 (8.8-10.0) 0.04
Aesthetics (0-10)
   Colour of  the crown
   Form of  the crown
   Colour of  the peri-implant mucosa














































   I regret that I chose this treatment
   I would recommend the treatment to 










































Abbreviations: NG group, No graft group; CTG group, Connective tissue graft group;  XCM 
group, Xenogeneic collagen matrix group; Tpre, pre-operative; T1, one month after final  
crown placement;  T12, twelve months after final crown placement. NA=Not assessed.







































Mesial/distal of  implant
   No papilla (score 0)
   Less than half  papilla (score 1)
   At least half  papilla (score 2)
   Entire papilla (score 3)
   Hyperplastic papilla (score 4)































Resulting negative values of  subtracting the baseline value (Tpre) from T1 and T1 from T12 means 
recession, positive values mean tissue gain. 
Abbreviations: NG group, No graft group; CTG group, Connective tissue graft group; XCM group, 
Xenogeneic collagen matrix group; Tpre, pre-operative; T1, one month after final crown placement; 
T12, twelve months after final crown placement; MBML, mid-buccal mucosal level; IML, 
interproximal mucosal level; MBL, marginal bone level.
NA=Not assessed; PES/WES not assessed at Tpre and T1, since T12 was most meaningful.




























Tpre (median (IQR)) p-value T1 (median (IQR)) p-value T12 (median (IQR)) p-value
VAS-questions (0-10)








0.65 8.1 (7.4-8.9) 7.5 (7.2-8.2) 8.8 (7.9-9.7) 0.01 8.2 (7.4-8.8) 7.9 (6.8-9.0) 8.8 (7.6-9.6) 0.27
How satisfied are you with 
your current dental situation 
compared to the situation 
before treatment? 
-- -- -- 8.6 (8.0-9.7) 8.4 (7.5-9.3) 9.2 (7.8-9.9) 0.37 8.5 (7.8-9.1) 8.5 (8.2-9.7) 9.3 (8.7-9.6) 0.15
How satisfied are you with the 
implant and the implant crown?
-- -- -- 8.9 (7.9-9.6) 8.6 (8.0-9.2) 9.7 (8.9-10.0) 0.02 8.7 (8.3-9.5) 8.4 (6.9-9.2) 9.3 (8.8-10.0) 0.04
Aesthetics (0-10)
   Colour of  the crown
   Form of  the crown
   Colour of  the peri-implant mucosa














































   I regret that I chose this treatment
   I would recommend the treatment to 










































Abbreviations: NG group, No graft group; CTG group, Connective tissue graft group;  XCM 
group, Xenogeneic collagen matrix group; Tpre, pre-operative; T1, one month after final  




This randomized controlled trial suggests that neither the application of  a CTG nor the 
application of  a XCM at implant placement in healed and preserved extraction sites results 
in a better retention of  the level of  the mid-buccal mucosa and to a better aesthetic outcome 
compared to the application of  no soft tissue graft at implant placement. 
The observed recession of  the mid-buccal mucosa in all groups in this study was minor and 
within clinically acceptable levels (Bienz et al. 2017). Changes in MBML in the NG group and 
CTG group were in line with recent literature (Stefanini et al. 2016, Slagter et al. 2016, Tonetti 
et al. 2017). Comparing the application of  a CTG to no soft tissue graft, we observed no 
difference for change in MBML, which is in line with a recent study (Bienz et al. 2017). The 
interpretation of  their results, however, is limited by the retrospective study design with a small 
sample size. Froum et al. (2015) evaluated the effect of  a XCM in a randomized controlled 
clinical trial compared to no soft tissue graft and reported a comparable outcome regarding 
the change in height and thickness of  the peri-implant soft tissues. However, the study of  
Froum et al. (2015) has limitations. Only patients with a thin and deficient keratinized mucosa 
needing an implant in the posterior region were included and were followed for just three 
months after surgery. This is in contrast to our study which evaluated single implant placement 
in the anterior maxilla up to one-year post-loading without selecting patients according to 
volume and width of  the keratinized mucosa. 
The fact that we observed no significant difference between the groups for change in MBML 
might be explained by the augmentation surgery of  fresh extraction sockets with slowly 
resorbing grafting material and sealing the socket with a mucosa graft, which has been demon-
strated to be beneficial in preserving the buccal bone and soft tissue contour (Raghoebar et al. 
2009, Jung et al. 2013). We like to hypothesize that this augmentation technique already may 
have contributed to the preservation of  sufficient peri-implant soft tissue, which in turn may 
have led to no further effect when applying a soft tissue graft at implant placement. 
The majority of  studies on the effect of  soft tissue grafting evaluate the change in mid-buccal 
mucosal volume (MBMV). Measurement of  the change in MBMV would have been desirable, 
but was beyond the scope of  this study. CT grafting could have resulted in an increase in the 
peri-implant soft tissue volume, which possibly compensated for the bone resorption induc-
ing effect of  flap elevation (Natto et al. 2017) in all study groups. Solely the last item in the 
PES judging root convexity, soft tissue texture and colour focuses on changes in soft tissue 
volume. However, this is a combined scoring item and only states whether all aspects (score 
2), two aspects (score 1) or only one/no aspect (score 0) are comparable to the contralateral 
tooth, limiting the sensitivity of  the PES to pick up small changes. The fact we could not 










find any differences between the groups for this item can be explained by this limitation of  
scoring this item of  the PES. 
Changes in marginal bone level in this study are in line with the changes observed in previ-
ous studies conducted by our group, in relation to the alveolar ridge preservation procedure 
(Raghoebar et al. 2009, Slagter et al. 2016). This is in contrast to Wiesner et al. (2010), who 
observed a higher loss of  marginal bone level in the test and control group. The limited change 
in bone level in this study may be explained by the reduced bone loss in a vertical direction 
as a result of  the ridge preservation procedure after removal of  the failing tooth (Araújo et 
al. 2015, MacBeth et al. 2017). 
With respect to aesthetics, no differences were found in the objective rating according to PES 
and WES. The rates were in line with recent literature (Slagter et al. 2016). Overall, patients 
were highly satisfied with the form and colour of  the peri-implant mucosa and the implant 
crown. The exception was the form of  the peri-implant mucosa in the CTG group at T1 (Table 
3), possibly because the CT grafted sites appeared immature and had not yet merged with the 
surrounding peri-implant mucosa, as observed by Nevins et al. (2011) This dissatisfaction 
was not observed anymore one year after the final implant crown was placed. Conversely, 
the patients were generally less satisfied with the CT grafted implant sites at T12. This might 
be explained by the higher patient morbidity when harvesting the CTG from the patient’s 
palate compared to those who had not received a graft or a XCM and thus did not have a 
second surgical site (Sanz et al. 2009, Cairo et al. 2017). Nevertheless, this could not be seen 
on comparing the question outcomes about whether they regretted choosing this treatment 
and whether they would recommend the treatment to others. 
Conclusion
The application of  a soft tissue graft combined with placement of  a single implant in a 
preserved alveolar ridge in the aesthetic zone does not result in a more favourable aesthetic 
outcome than when no soft tissue graft was applied during implant placement. Thus, soft 
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